Tyck till om SwePub Sök här!
WFRF:(Stroes E)
Search: WFRF:(Stroes E) > Homozygous familial...
- 3 of 27
- Previous record
- Next record
- To hitlist
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cuchel, M. (author)
- Bruckert, E. (author)
- Ginsberg, H. N. (author)
- show more...
- Raal, F. J. (author)
- Santos, R. D. (author)
- Hegele, R. A. (author)
- Kuivenhoven, J. A. (author)
- Nordestgaard, B. G. (author)
- Descamps, O. S. (author)
- Steinhagen-Thiessen, E. (author)
- Tybjrg-Hansen, A. (author)
- Watts, G. F. (author)
- Averna, M. (author)
- Boileau, C. (author)
- Catapano, A. L. (author)
- Defesche, J. C. (author)
- Hovingh, G. K. (author)
- Humphries, S. E. (author)
- Kovanen, P. T. (author)
- Masana, L. (author)
- Pajukanta, P. (author)
- Parhofer, K. G. (author)
- Ray, K. K. (author)
- Stalenhoef, A. F. H. (author)
- Stroes, E. (author)
- Taskinen, M. R. (author)
- Wiegman, A. (author)
- Wiklund, Olov, 1943 (author)
- Chapman, M. J. (author)
- show less...
- (creator_code:org_t)
- 2014-07-22
- 2014
- English.
- In: European Heart Journal. - : Oxford University Press (OUP). - 0195-668X .- 1522-9645. ; 35:32
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Aims Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease (ACVD). Given recent insights into the heterogeneity of genetic defects and clinical phenotype of HoFH, and the availability of new therapeutic options, this Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) critically reviewed available data with the aim of providing clinical guidance for the recognition and management of HoFH. Methods and results Early diagnosis of HoFH and prompt initiation of diet and lipid-lowering therapy are critical. Genetic testing may provide a definitive diagnosis, but if unavailable, markedly elevated LDL-C levels together with cutaneous or tendon xanthomas before 10 years, or untreated elevated LDL-C levels consistent with heterozygous FH in both parents, are suggestive of HoFH. We recommend that patients with suspected HoFH are promptly referred to specialist centres for a comprehensive ACVD evaluation and clinical management. Lifestyle intervention and maximal statin therapy are the mainstays of treatment, ideally started in the first year of life or at an initial diagnosis, often with ezetimibe and other lipid-modifying therapy. As patients rarely achieve LDL-C targets, adjunctive lipoprotein apheresis is recommended where available, preferably started by age 5 and no later than 8 years. The number of therapeutic approaches has increased following approval of lomitapide and mipomersen for HoFH. Given the severity of ACVD, we recommend regular follow-up, including Doppler echocardiographic evaluation of the heart and aorta annually, stress testing and, if available, computed tomography coronary angiography every 5 years, or less if deemed necessary. Conclusion This EAS Consensus Panel highlights the need for early identification of HoFH patients, prompt referral to specialized centres, and early initiation of appropriate treatment. These recommendations offer guidance for a wide spectrum of clinicians who are often the first to identify patients with suspected HoFH.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- Homozygous familial hypercholesterolaemia
- Diagnosis
- Genetics
- Phenotypic heterogeneity
- Statins
- DENSITY-LIPOPROTEIN CHOLESTEROL
- TRIGLYCERIDE TRANSFER PROTEIN
- CORONARY-HEART-DISEASE
- LIVER-TRANSPLANTATION
- MONOCLONAL-ANTIBODY
- APOLIPOPROTEIN-B
- LDL-APHERESIS
- PLASMA-CHOLESTEROL
- CONTROLLED-TRIAL
- AORTIC-STENOSIS
- Cardiac & Cardiovascular Systems
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- European Heart Journal (Search for host publication in LIBRIS)
To the university's database
- 3 of 27
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Cuchel, M.
- Bruckert, E.
- Ginsberg, H. N.
- Raal, F. J.
- Santos, R. D.
- Hegele, R. A.
- show more...
- Kuivenhoven, J. ...
- Nordestgaard, B. ...
- Descamps, O. S.
- Steinhagen-Thies ...
- Tybjrg-Hansen, A ...
- Watts, G. F.
- Averna, M.
- Boileau, C.
- Borén, Jan, 1963
- Catapano, A. L.
- Defesche, J. C.
- Hovingh, G. K.
- Humphries, S. E.
- Kovanen, P. T.
- Masana, L.
- Pajukanta, P.
- Parhofer, K. G.
- Ray, K. K.
- Stalenhoef, A. F ...
- Stroes, E.
- Taskinen, M. R.
- Wiegman, A.
- Wiklund, Olov, 1 ...
- Chapman, M. J.
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cardiac and Card ...
- Articles in the publication
- European Heart J ...
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
